Colgate-Palmolive Company $CL Position Lessened by GUARDCAP ASSET MANAGEMENT Ltd

GUARDCAP ASSET MANAGEMENT Ltd cut its stake in Colgate-Palmolive Company (NYSE:CL) by 15.2% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 2,979,811 shares of the company’s stock after selling 535,667 shares during the quarter. Colgate-Palmolive comprises about 6.3% of GUARDCAP ASSET MANAGEMENT Ltd’s portfolio, making the stock its 7th biggest position. GUARDCAP ASSET MANAGEMENT Ltd owned approximately 0.37% of Colgate-Palmolive worth $235,419,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds have also made changes to their positions in CL. CBIZ Investment Advisory Services LLC increased its holdings in shares of Colgate-Palmolive by 86.7% in the 4th quarter. CBIZ Investment Advisory Services LLC now owns 323 shares of the company’s stock valued at $26,000 after acquiring an additional 150 shares during the period. Maseco LLP purchased a new position in shares of Colgate-Palmolive in the 4th quarter valued at $27,000. Global Wealth Strategies & Associates increased its holdings in shares of Colgate-Palmolive by 300.0% in the 4th quarter. Global Wealth Strategies & Associates now owns 400 shares of the company’s stock valued at $32,000 after acquiring an additional 300 shares during the period. Grove Bank & Trust increased its holdings in shares of Colgate-Palmolive by 182.6% in the 4th quarter. Grove Bank & Trust now owns 407 shares of the company’s stock valued at $32,000 after acquiring an additional 263 shares during the period. Finally, Camelot Portfolios LLC purchased a new position in shares of Colgate-Palmolive in the 4th quarter valued at $32,000. 80.41% of the stock is currently owned by hedge funds and other institutional investors.

Colgate-Palmolive Stock Down 1.5%

Shares of CL stock opened at $90.26 on Friday. Colgate-Palmolive Company has a 1-year low of $74.54 and a 1-year high of $99.33. The stock’s fifty day moving average price is $86.29 and its 200 day moving average price is $85.64. The company has a debt-to-equity ratio of 16.33, a current ratio of 1.02 and a quick ratio of 0.67. The company has a market cap of $72.22 billion, a price-to-earnings ratio of 35.12, a price-to-earnings-growth ratio of 4.68 and a beta of 0.31.

Colgate-Palmolive (NYSE:CL) last announced its earnings results on Friday, May 1st. The company reported $0.97 earnings per share for the quarter, topping the consensus estimate of $0.94 by $0.03. Colgate-Palmolive had a return on equity of 386.76% and a net margin of 10.04%.The firm had revenue of $5.32 billion for the quarter, compared to the consensus estimate of $5.22 billion. During the same period in the previous year, the business earned $0.91 EPS. The firm’s revenue for the quarter was up 8.4% on a year-over-year basis. On average, research analysts expect that Colgate-Palmolive Company will post 3.82 earnings per share for the current fiscal year.

Colgate-Palmolive Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, May 15th. Shareholders of record on Monday, April 20th were paid a dividend of $0.53 per share. This represents a $2.12 annualized dividend and a yield of 2.3%. The ex-dividend date was Monday, April 20th. This is a boost from Colgate-Palmolive’s previous quarterly dividend of $0.52. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 82.49%.

Analysts Set New Price Targets

CL has been the topic of a number of analyst reports. TD Cowen reiterated a “hold” rating and issued a $85.00 price target on shares of Colgate-Palmolive in a report on Tuesday, March 31st. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and issued a $99.00 price target on shares of Colgate-Palmolive in a report on Monday, May 4th. Weiss Ratings upgraded Colgate-Palmolive from a “hold (c)” rating to a “hold (c+)” rating in a research note on Monday, May 4th. Barclays boosted their target price on Colgate-Palmolive from $79.00 to $80.00 and gave the stock an “equal weight” rating in a research note on Tuesday, May 5th. Finally, Wells Fargo & Company dropped their target price on Colgate-Palmolive from $100.00 to $92.00 and set an “equal weight” rating on the stock in a research note on Wednesday, April 8th. Twelve research analysts have rated the stock with a Buy rating and six have given a Hold rating to the stock. According to data from MarketBeat.com, Colgate-Palmolive has a consensus rating of “Moderate Buy” and a consensus price target of $95.88.

Colgate-Palmolive Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.